Nanjing, China

Xiaolong Hu

This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaolong Hu. Retrieved from https://idiyas.com/inventor/xiaolong-hu-rz6kcf0n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaolong Hu and His Work in Medicinal Chemistry

Introduction

Xiaolong Hu is an inventor associated with China Pharmaceutical University in Nanjing, China. His patent work concerns cinnamoyl amino acid compounds and their potential pharmaceutical applications.

Latest Patents

Hu is named on 1 patent: “Cinnamoyl Amino Acid Compound and Use Thereof.” The patent describes cinnamoyl amino acid compounds with inducible nitric oxide synthase (iNOS) inhibitory activity, or pharmaceutically acceptable salts of those compounds. It also covers pharmaceutical compositions containing them and their potential medical uses.

The disclosed research focuses particularly on preventing or treating neurodegenerative conditions associated with nerve-cell damage, including ischemic stroke and Parkinson’s disease. These proposed applications connect medicinal chemistry with pharmacotherapeutic research.

Career Highlights

Hu’s listed patent reflects research into compounds that may inhibit iNOS and support the development of treatments for neurological conditions. His affiliation with China Pharmaceutical University places this work within a university research setting.

Collaborations

Hao Wang and Xianyu Lv are identified as Hu’s coworkers. Their names are associated with the collaborative research context of the patent.

Conclusion

Xiaolong Hu’s patent activity centers on cinnamoyl amino acid compounds and their potential role in addressing nerve-cell damage, highlighting a research focus at the intersection of medicinal chemistry and neurological therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…